All Members

Novartis Baltics

Industry: Healthcare/Pharmaceuticals
Website: http://www.novartis.lv
http://www.novartis.com
http://www.pharma.us.novartis.com
Level: Corporate Contributing

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com Novartis operates in Latvia since 1996. We are amongst top pharmaceutical companies by sales value and clinical trial sponsors in Latvia.

< Back to Members

Feedback

In Nasdaq we strive to build sustainable principles into our solutions because it is the key to long-term global prosperity. AmCham is an organization where well-governed and transparent companies of different sizes and origins meet. This is why I am delighted to contribute to improving the business culture and corporate governance through AmCham.

Liene Dubava, Chair of the Management Board of Nasdaq Riga Stock Exchange

Being part of AmCham community brings valuable networking opportunities in different business areas as well as informal connections within Business After Hours.

Janis Zigurs, Business Manager Baltics & Iceland at Kenvue